ESR1 and prostate neoplasm: As morphology and initial IHC evaluation (GATA-3 and ER positivity) could not completely exclude urothelial primary with prostatic duct involvement, morphologic, and IHC comparison of the patient's primary breast cancer and current prostatic neoplasm was necessary [9, 18].